Zepbound Side Effects (2026): Nausea 29%, Diarrhea 23%, Vomiting 13% — Full Guide with SURMOUNT Trial Data

Verified April 2026: The most common Zepbound (tirzepatide) side effects are nausea (24-29%), diarrhea (19-23%), constipation (11-17%), vomiting (8-13%), and stomach pain (5-7%), according to data from the SURMOUNT-1 and SURMOUNT-2 clinical trials enrolling 2,519 patients on tirzepatide. At the highest dose (15 mg), only 4.3% of patients discontinued due to GI side effects — meaning 95.7% were able to continue treatment. In the head-to-head SURMOUNT-5 trial, tirzepatide had a lower GI-related discontinuation rate than semaglutide (2.7% vs 5.6%), confirming Zepbound is measurably more tolerable than Wegovy. For our full comparison of all GLP-1 side effects including semaglutide, see our complete GLP-1 side effects management guide.

Common Zepbound Side Effects by Dose: SURMOUNT Trial Data

Zepbound uses a dose-escalation schedule starting at 2.5 mg and increasing every 4 weeks to maintenance doses of 5 mg, 10 mg, or 15 mg. Side effect rates vary significantly by dose — higher doses cause more GI symptoms, but also produce more weight loss (up to 22.5% body weight reduction at 15 mg in SURMOUNT-1). Here is what the Zepbound prescribing information reports from pooled SURMOUNT trial data:

Two patterns matter here. First, nausea peaks at the 10 mg dose (29%) and actually decreases slightly at 15 mg (28%) — suggesting the body adapts during escalation. Second, the discontinuation rate even at the highest dose is only 4.3%, meaning the vast majority of patients found the side effects manageable enough to continue treatment. For context, the SURMOUNT-5 head-to-head trial showed Zepbound's GI discontinuation rate (2.7%) was roughly half that of semaglutide (5.6%).

When Do Zepbound Side Effects Start — and When Do They Stop?

The timeline of Zepbound side effects follows a predictable pattern tied to the dose-escalation schedule. Most patients experience the worst GI symptoms in the first 2-4 days after each dose increase, with symptoms gradually fading over the following 2-3 weeks as the body adjusts.

• •Weeks 1-4 (2.5 mg starting dose): Mild nausea for 50-60% of patients. This is the lowest dose and is not a therapeutic dose — it exists solely to let your body adjust. Most patients report manageable symptoms.
• •Weeks 5-8 (5 mg): First real dose increase. Nausea tends to peak in days 1-3 after the step-up, then settles by day 7-10. About 24% of patients experience nausea at this dose per SURMOUNT data.
• •Weeks 9-12 (7.5 mg): Intermediate step. Side effects are typically milder than the 5 mg step because the incremental change is smaller. Many patients report this as the easiest dose increase.
• •Weeks 13-16 (10 mg): Significant dose jump. Nausea rates peak at 29%. This is where most patients who will experience notable side effects feel them most intensely.
• •Weeks 17-20 (12.5 mg → 15 mg): Final escalation. By this point, most patients have developed tolerance. The 4.3% discontinuation rate at 15 mg is a cumulative number — patients who couldn't tolerate GI effects already dropped out at lower doses.
• •Month 5+ (maintenance): GI side effects are typically minimal at maintenance dose. Most patients report that nausea, diarrhea, and vomiting have largely resolved. The SURMOUNT-1 trial 72-week data confirms this pattern.

How to Manage Zepbound Side Effects: Evidence-Based Strategies

The management strategies below come from clinical practice guidelines, published patient-reported outcomes, and the Zepbound prescribing information. Most GI side effects can be managed without medication changes.

Nausea (24-29%)

• •Eat smaller, more frequent meals — 5-6 mini-meals instead of 3 large ones. Zepbound slows gastric emptying, so large meals sit in your stomach too long.
• •Avoid high-fat and fried foods — Fat takes the longest to digest. Lean proteins, whole grains, and vegetables are better tolerated. See our foods to avoid on GLP-1 guide.
• •Time your injection before bed — Many patients inject in the evening so the 6-12 hour peak nausea window passes during sleep.
• •Ginger is evidence-backed — Ginger tea, ginger chews, or ginger capsules (250 mg, up to 4x daily) have demonstrated antiemetic properties in clinical research.
• •Ask about ondansetron (Zofran) — If nausea is severe, your prescriber can add a short-term anti-nausea prescription for the first week at each new dose.

Diarrhea (19-23%)

• •Hydrate with electrolytes — Diarrhea depletes water and minerals. Add an oral rehydration solution or electrolyte powder to your daily water intake.
• •Avoid artificial sweeteners — Sugar alcohols (sorbitol, erythritol) in sugar-free products worsen diarrhea.
• •BRAT diet during acute episodes — Bananas, rice, applesauce, and toast help firm stools.
• •Call your provider if it persists >72 hours — Prolonged diarrhea can cause dehydration, which in turn increases risk of acute kidney injury (see serious side effects below).

Constipation (11-17%)

• •Increase fiber gradually — Add vegetables, fruits, and whole grains, but increase slowly to avoid worsening symptoms.
• •Drink 64+ oz of water daily — Reduced food intake means less water from food, making dehydration-driven constipation more common.
• •Magnesium citrate at bedtime — 200-400 mg is a gentle osmotic laxative many GLP-1 patients use daily. Also helps with sleep and muscle cramps.
• •Move your body — A 20-minute daily walk stimulates gut motility and is one of the most effective natural constipation remedies.

Injection Site Reactions (3-7%)

• •Rotate injection sites — Alternate between abdomen, thigh, and upper arm. Never inject in the same spot twice in a row.
• •Let the pen warm to room temperature — Remove from refrigerator 30 minutes before injection. Cold medication stings more.
• •Apply a cold compress after — 5-10 minutes of ice can reduce redness and swelling at the site.

Zepbound Hair Loss: What the SURMOUNT Trials Show

Hair loss is one of the most-searched Zepbound side effects. The data: 4-6% of Zepbound patients in the SURMOUNT trials reported alopecia, compared to 1% on placebo. The Zepbound prescribing information notes that hair loss was associated with weight loss itself (not the drug mechanism) and occurred more frequently in women than men.

This type of hair loss is called telogen effluvium — a temporary shedding condition triggered by rapid weight change, major surgery, or physiological stress. It is not permanent hair loss. The same pattern occurs after bariatric surgery at similar rates. Key facts:

• •Onset: Typically 2-4 months after significant weight loss begins, not immediately after starting Zepbound.
• •Duration: Peaks around month 6, then resolves over 6-12 months as the body adjusts to its new weight.
• •Hair follicles are not damaged — They shift temporarily into a resting phase. New growth follows.
• •Mitigation: Ensure adequate protein intake (60-80g daily minimum), check iron/vitamin D/zinc levels, and consider biotin supplementation (2,500-5,000 mcg daily).

For a deeper dive into hair loss and other weight-loss-associated side effects like facial volume loss and muscle loss, see our comprehensive GLP-1 side effects guide.

Serious Zepbound Side Effects: FDA Warnings and Red Flags

While the vast majority of Zepbound side effects are GI-related and temporary, the FDA prescribing information includes several serious warnings that every patient should understand before starting treatment.

Acute pancreatitis — Reported in 0.2% of Zepbound-treated patients in clinical trials (0.14 per 100 patient-years of exposure), a rate similar to placebo. Symptoms: severe, persistent upper abdominal pain radiating to the back, with nausea and vomiting. This is distinctly different from routine GI discomfort — the pain is sharp, intense, and unrelenting. Stop Zepbound and seek emergency care if suspected. Risk factors: history of pancreatitis, gallstones, and heavy alcohol use.

Gallbladder disease — Cholelithiasis (gallstones) was reported in 1.1% of Zepbound patients vs 1.0% on placebo. Cholecystitis (gallbladder inflammation) occurred in 0.7% vs 0.2% on placebo — a meaningful difference. Rapid weight loss increases gallstone risk regardless of method. Symptoms: severe pain in the upper right abdomen (especially after eating fatty meals), fever, and jaundice (yellowing of skin/eyes).

Acute kidney injury — Reported in post-marketing surveillance. Mechanism: severe nausea, vomiting, or diarrhea → dehydration → kidney stress. This is preventable — aggressive hydration during GI symptom flares is critical. Contact your provider if you notice dark urine, significantly reduced urination, or swelling in your legs/ankles.

Hypoglycemia — Reported in 4.2% of Zepbound patients vs 1.3% on placebo. Risk is higher if you take Zepbound with insulin or a sulfonylurea (diabetes medications). Symptoms: shakiness, sweating, confusion, rapid heartbeat. Zepbound is FDA-approved for chronic weight management — it is not the same as Mounjaro (tirzepatide for type 2 diabetes), which has different dosing and monitoring requirements.

Suicidal ideation — The FDA requires monitoring for suicidal behavior and ideation in patients taking Zepbound. In SURMOUNT trials, the incidence was low and comparable to placebo, but the FDA included this warning based on post-marketing reports across the GLP-1 class. Tell your provider immediately if you experience depression, mood changes, or thoughts of self-harm. Visit our Safety Center for more information on GLP-1 medication safety.

Zepbound vs Wegovy Side Effects: Head-to-Head Comparison

The SURMOUNT-5 trial (published 2024, New England Journal of Medicine) is the only head-to-head comparison of tirzepatide (Zepbound) vs semaglutide (Wegovy) for weight loss. It enrolled 751 adults and ran for 72 weeks.

Zepbound produced 47% more weight loss while causing significantly fewer GI side effects across every major category. The GI-related discontinuation rate was less than half that of Wegovy. This matters because GI side effects are the #1 reason patients stop GLP-1 medications. For a full comparison of these two medications beyond side effects — including cost, availability, and mechanism — see our detailed Wegovy vs Zepbound analysis. If you are choosing between providers that offer Zepbound, our rankings table compares 40 telehealth programs by cost, clinical quality, and medication options.

When to Call Your Doctor About Zepbound Side Effects

Most Zepbound side effects are manageable at home. But certain symptoms require immediate medical attention. Call your prescribing provider or go to the ER if you experience:

• •Severe abdominal pain that is persistent, sharp, and radiates to your back (possible pancreatitis)
• •Inability to keep liquids down for 24+ hours (risk of dehydration and kidney injury)
• •Dark urine or dramatically reduced urination (possible kidney injury)
• •Severe upper-right abdominal pain with fever (possible gallbladder disease)
• •A lump in your neck, persistent hoarseness, or difficulty swallowing (thyroid evaluation needed per boxed warning)
• •Signs of severe allergic reaction: facial swelling, difficulty breathing, rapid heartbeat, severe rash
• •Thoughts of self-harm or suicidal ideation — contact your provider immediately or call the 988 Suicide & Crisis Lifeline (call or text 988)

For routine side effects that are uncomfortable but not dangerous, your provider can help by adjusting your dose schedule, prescribing anti-nausea medication, or recommending a temporary dose hold. Don't suffer in silence — most telehealth GLP-1 providers offer messaging access to your clinical team between visits. Use our eligibility checker or take the quiz to find a provider that matches your needs.

Frequently Asked Questions

How long do Zepbound side effects last?

Most GI side effects (nausea, diarrhea, vomiting) peak in the first 2-4 days after each dose increase and resolve within 2-3 weeks. By month 5 on a stable maintenance dose, the majority of patients report minimal or no GI symptoms. Hair loss, if it occurs, typically starts 2-4 months into treatment and resolves within 6-12 months.

Is Zepbound safer than Wegovy?

In the head-to-head SURMOUNT-5 trial, Zepbound had a GI-related discontinuation rate of 2.7% compared to 5.6% for Wegovy — roughly half the dropout rate for GI reasons. Nausea rates were also significantly lower (24-29% vs 44%). Both drugs carry similar serious warnings (thyroid, pancreatitis, gallbladder), but for day-to-day tolerability, the clinical data favors Zepbound.

Does Zepbound cause permanent hair loss?

No. Zepbound-associated hair loss is telogen effluvium — temporary shedding caused by rapid weight loss, not the drug itself. Hair follicles are not damaged and regrowth occurs within 6-12 months. The same pattern occurs after bariatric surgery and other rapid weight loss methods.

Can I take Zepbound if I've had pancreatitis?

A history of pancreatitis is a risk factor. The FDA does not list it as a contraindication, but recommends caution. Discuss your history with your prescribing provider, who can weigh the risks and benefits for your specific situation. If you do take Zepbound, report any severe abdominal pain immediately.

What is the cheapest way to get Zepbound?

With commercial insurance and the Zepbound savings card, you may pay as little as $25/month. Without insurance, the lowest self-pay options for compounded tirzepatide start at $99/month through telehealth providers like Sesame Care and $115/month through Enhance MD. Brand-name Zepbound is $1,059/month list price without insurance. See our full cheapest tirzepatide guide for all options.